From Alliance for Contraception In Cats & Dogs (ACC-D):

We hope you’re enjoying a safe, warm, and happy holiday season.

Here at ACC&D, we’re celebrating an exciting and productive Third International Symposium (for non-surgical animal contraception) just a few weeks ago! To those of you who were able to join us, thank you for your active participation and valuable contributions. For those who were unable to attend, you'll find quick highlights below and a brief report here.

Raising awareness of the potential of non-surgical sterilization increases both support and demand. Please take a moment to forward this link to your animal-loving contacts.

Sincerely,
Joyce Briggs, President


Third International Symposium

120 attendees from nine countries convened in Alexandria, Virginia, to advance progress in developing and using non-surgical contraception to manage dog and cat populations. Here are just a few of the highlights:

-Intervet announced the European launch of Gonazon®, a one-year, reversible contraceptive implant for female dogs. Data for this product with cats shows three-year contraception so far!

-Research from Senestech shows early results that “Chemspay” a new drug approach, permanently sterilizes female dogs. Work in cats has just begun.

-It was announced that Abbott Laboratories will manufacture and distribute Neutersol®, brand name for zinc gluconate, in the United States.

-Head of the Mexican veterinary medical association shared positive results using zinc gluconate in 10,000 dogs in Mexico. Could this reach the 15-18 million dogs vaccinated by the government for rabies each year?

-U.S. charities and veterinarians subsidizing spay/neuter could save more than $53 million a year, with even a moderately priced alternative.

-ACC&D announced a plan which includes support of the international use of zinc gluconate, a partnership with holder of early stage technology for female dogs and cats, and a goal to raise $10 million to support this work.

---

---

---

---

---

---